We are live on
!
Find out more
RXII
GALENA BIOPHARMA INC COM
RXII
RXII
Delisted
RXII was delisted on the 25th of October, 2011.
90 hedge funds and large institutions have $14.4M invested in GALENA BIOPHARMA INC COM in 2016 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 28 increasing their positions, 16 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
376% more call options, than puts
Call options by funds: $3.93M | Put options by funds: $825K
333% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 6
75% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 16
27% more funds holding
Funds holding: 71 → 90 (+19)
61% less capital invested
Capital invested by funds: $36.5M → $14.4M (-$22.1M)
Holders
90
Holders Change
+19
Holders Change %
+26.76%
% of All Funds
2.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
28
Reduced
16
Closed
6
Calls
$3.93M
Puts
$825K
Net Calls
+$3.1M
Net Calls Change
-$4.74M
Top Buyers
| 1 |
Group One Trading
Chicago,
Illinois
|
+$450K |
| 2 |
State Street
Boston,
Massachusetts
|
+$164K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$114K |
| 4 |
Goldman Sachs
New York
|
+$90.1K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$77K |
Top Sellers
| 1 |
Parallax Volatility Advisers
San Francisco,
California
|
-$148K |
| 2 |
D.E. Shaw & Co
New York
|
-$97.5K |
| 3 |
Citigroup
New York
|
-$64.2K |
| 4 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
-$53.6K |
| 5 |
Morgan Stanley
New York
|
-$39.3K |
